OneMedPlace Announces “OneMedForum 2011” Finance Conference for Emerging Healthcare and Life Science Companies


OneMedPlace announced today that its “OneMedForum 2011” business development and finance conference for emerging healthcare and life science companies will be held January 11-13, 2011, in San Francisco at the Sir Francis Drake Hotel. The 4th annual OneMedForum event continues to be a vital connecting point for emerging companies, business development executives and investors involved in the healthcare/life sciences sector.

The three-day event will include sector-focused panel sessions, numerous networking opportunities and more than 125 presentations from some of the most promising emerging medical device, biotech and health information companies.

“Our mission is one of discovery. And our goal is to find the most promising and least known investment and partnering opportunities among both public and private companies. We have already enrolled nearly 50 very promising companies and are continuing to tap our investor network to identify additional companies with promise,” said Brett Johnson, CEO of OneMedPlace and founder of the OneMedForum.

The format of OneMedForum combines both strategy and company presentations. Focused panels of leading investors will be followed by 8-10 minute presentations by senior management of companies with the most interesting new technologies in that field. Panelists will include well-known strategic and institutional investors in Urology, Women’s Health, Cardiology, Orthopedics, Diagnostics, Oncology and Neurology.

The event will showcase 60 microcap public companies. Organizers have been working with investment boutiques focused on devices, biotech and information services to find those companies with little or no coverage but with big prospects. “Tight crisp presentations will be webcast by OneMedTV to a growing network of investors and corporate and strategic investors in North America, Europe and Asia”, said Johnson. At its 3rd Annual OneMedForum SF 2010, company webcasts had over 15,000 views from more than 9,000 investors.

“This OneMedForum has evolved into the premier gathering pairing promising young companies with corporate, institutional, venture and private equity investors,” said Casey McGlynn, Co-Chair of the OneMedForum Advisory Committee and Chair of the Life Sciences practice at Wilson Sonsini Goodrich & Rosatti. “It has proven to make a difference in the prospects of these firms to connect them with investors and partners,” added McGlynn.

“This event is a particularly effective opportunity to gain exposure to numerous investors because it is concurrent with the other investor events in close proximity. These events truly draw the world leaders in investment from around the globe,” said Christian Haller of MPR Associates, a leading global developer of medical devices and sponsor of the OneMedForum.

Companies confirmed to present as of October 18th include: Aduro Biotech, ADVENTRX Pharmaceuticals, AesRx, Ascalon International, BioCurex, Biovista, Cambridge Heart, Cardiogenesis, CardioPolymers, Cardium Therapeutics, Cyclacel Pharmaceuticals, Cytori Therapeutics, DataPhysics Research, ECI Biotech, EMKinetics, EpiCept, Healthlink Europe, Intellectual Ventures, IntelleWave, Interface Biologics, JenaValve Technologies, Macuclear, Minnow Medical, Myeloma Health, NeoChord, NeoVista, Neurotez, New World Laboratories, Novadaq Technologies, Oculus Innovative Sciences, Ophthalmic Imaging Systems, OptiMedica, Ortho Kinematics, Oxygen Biotherapeutics, Ovatech, PearlDiver, PCAsso Diagnostics, Pico-Tesla Magnetic Therapies, Pressure BioSciences, Prochon Biotech, RepRegen, S.E.A. Medical Systems, Soft Tissue Regeneration, Sound Surgical Technologies, Spherix, Telcare, Telik, Velomedix, Vyteris, and ZS Pharma.

The comments are closed.